Receiver operating characteristic (ROC) analysis for complement C3, beta-2-microglobulin and peroxiredoxin 2 indicate that they only have weak discriminatory (accuracy ranged between 60 and 65%) ability to distinguish between cognitively normal from AD (Table 4). This evidence concerns the gene PRDX2 and Alzheimer disease.